ArticleTranslational oncology2013

HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.

Jay A Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.